Sunil Healthcare quarterly results and financials

Sunil Healthcare (BSE 537253)₹70.50+0.40%(25 Sept 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Sunil Healthcare reported sales of ₹18.94 Cr, down 16.2% from Jun 2025, and net profit of ₹0.45 Cr, down 50.0% year on year. For the year to Mar 2026, sales were ₹87.48 Cr and net profit ₹4 Cr.

Sales (Jun 2026): ₹18.94 Cr
Net profit (Jun 2026): ₹0.45 Cr
Sales (FY Mar 2026): ₹87.48 Cr
Net profit (FY Mar 2026): ₹4 Cr
EPS (Jun 2026): ₹0.46
Borrowings (Mar 2026): ₹55.86 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Sunil Healthcare quarterly results

₹ crore unless stated; each column is a quarter.

Sunil Healthcare Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	23.64	22.61	21.27	21.45	20.21	20.42	21.15	22.61	23.46	21.80	19.67	18.94
Expenses	22.50	23.32	18.67	19.32	17.98	17.77	18.18	19.40	19.62	18.25	17.80	16.07
Operating Profit	1.23	−0.64	2.69	2.22	2.32	2.71	3.04	3.28	3.95	3.63	1.95	2.94
OPM %	5.2%	−2.8%	12.6%	10.3%	11.4%	13.3%	14.3%	14.5%	16.7%	16.6%	9.9%	15.5%
Other Income	0.21	3.12	0.67	0.13	0.17	0.52	0.48	0.85	0.41	0.49	0.28	0.22
Interest	1.30	1.43	1.75	1.50	1.49	1.88	1.55	1.43	1.39	1.65	1.65	1.49
Depreciation	1.58	1.44	1.42	1.47	1.50	1.68	1.67	1.65	1.63	1.61	1.51	1.45
Profit before tax	−1.47	−0.40	0.18	−0.65	−0.53	−0.36	0.29	1.04	1.32	0.85	−0.96	0.21
Tax %	−25.3%	−48.6%	5.9%	6.3%	7.8%	57.2%	−28.5%	11.7%	23.7%	31.0%	−258.9%	−129.9%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−0.11	0.00
Net Profit	−1.09	−0.19	0.14	−0.68	−0.54	−0.53	0.35	0.90	0.99	0.58	1.51	0.45
EPS (Rs)	−1.08	−0.21	0.16	−0.68	−0.55	−0.54	0.36	0.90	0.99	0.59	1.49	0.46

Sunil Healthcare profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Sunil Healthcare Profit and loss
	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	108	91.10	80.65	69.85	90.49	119	110	90.02	83.20	87.48	83.87
Expenses	93.49	77.57	69.68	77.01	85.35	102	94.46	86.10	73.11	75.05	71.74
Operating Profit	15.21	13.95	11.30	−6.95	5.37	17.46	16.23	4.28	10.40	12.81	12.47
OPM %	14.0%	15.3%	14.0%	−9.9%	5.9%	14.6%	14.7%	4.7%	12.5%	14.6%	14.9%
Other Income	1.24	2.22	0.17	14.37	5.51	1.67	4.49	5.04	1.23	2.05	1.40
Interest	4.17	5.01	6.56	6.92	5.29	3.48	4.16	5.76	6.44	6.14	6.18
Depreciation	4.32	4.77	5.73	6.12	6.10	6.30	7.00	6.08	6.34	6.43	6.20
Profit before tax	7.91	6.32	−0.89	−5.61	−0.56	9.27	9.51	−2.57	−1.22	2.24	1.42
Tax %	36.3%	28.7%	−20.4%	−11.2%	16.4%	30.7%	29.5%	−30.0%	16.6%	−79.3%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−0.11
Net Profit	5.02	4.48	−0.68	−4.95	−0.63	6.41	6.67	−1.78	−1.41	4.00	3.53
EPS (Rs)	4.92	4.39	−0.68	−4.85	−0.63	6.28	6.52	−1.76	−1.39	3.92	3.53
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Sunil Healthcare balance sheet

₹ crore, at each year end.

Sunil Healthcare Balance sheet
	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.24	10.24	10.24	10.24	10.24	10.24	10.24	10.24	10.24	10.24
Reserves	32.68	37.22	36.51	34.35	33.47	39.71	45.78	57.95	56.88	59.33
Borrowings	44.62	60.68	55.20	49.55	49.92	34.73	36.86	66.24	68.71	55.86
Other Liabilities	31.39	34.15	35.89	36.19	27.01	25.10	27.98	24.14	26.32	39.19
Total Liabilities	119	142	138	130	121	110	121	159	162	165
Fixed Assets	59.90	71.13	69.01	70.15	69.99	70.11	70.57	87.39	94.40	86.14
CWIP	0.11	0.18	2.46	0.00	0.00	1.74	0.00	5.65	0.08	1.76
Investments	0.00	0.11	0.12	0.12	1.08	1.04	0.00	0.00	0.00	0.00
Other Assets	58.92	70.87	66.25	60.06	49.57	36.89	50.29	65.53	67.67	76.72
Inventories	10.76	10.11	16.55	24.80	13.69	11.02	13.56	14.01	17.61	18.69
Trade receivables	38.46	48.04	39.17	23.52	23.37	18.87	28.37	40.49	41.55	45.07
Cash & equivalents	3.92	4.82	2.68	4.99	8.26	3.45	3.93	3.60	3.08	2.32
Total Assets	119	142	138	130	121	110	121	159	162	165

Sunil Healthcare cash flow

₹ crore, for each year.

Sunil Healthcare Cash flow
	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	10.78	5.47	14.71	4.30	16.98	22.49	7.46	−15.41	11.51	22.14
Cash from investing activity	−12.84	−17.19	−2.81	−2.53	−11.35	−4.23	−3.41	−10.10	−7.69	−2.84
Cash from financing activity	2.22	11.01	−11.62	−1.55	−6.41	−18.54	−3.74	24.96	−3.86	−19.25
Net cash flow	0.18	−0.68	0.31	0.24	−0.80	−0.30	0.33	−0.52	−0.06	0.05
Capex	13.34	15.64	5.60	0.82	6.85	9.06	4.21	10.49	9.46	3.60
Free cash flow	−2.16	−10.14	9.23	3.64	10.29	13.51	3.98	−25.61	2.53	18.62
CFO / OP %	82.1%	50.0%	134.1%	−63.9%	315.1%	136.1%	55.0%	−343.9%	111.1%	173.1%

Sunil Healthcare ratios

Working-capital days and returns, by year.

Sunil Healthcare Ratios
	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	130	192	177	123	94	58	94	164	182	188
Inventory days	76	102	213	323	117	83	105	111	176	209
Days payable	140	181	295	294	110	66	115	49	90	179
Cash conversion cycle	68	115	97	154	103	77	86	228	270	220
Working capital days	−12	−16	−51	−64	−53	−26	−4	6	−3	22
ROCE %	—	11.7%	5.5%	1.7%	5.1%	14.3%	15.3%	3.0%	4.0%	6.5%

Sunil Healthcare: frequently asked questions

What are the latest quarterly results of Sunil Healthcare?

For the Jun 2026 quarter, Sunil Healthcare reported sales of ₹18.94 Cr, down 16.2% year on year and net profit of ₹0.45 Cr, down 50.0% year on year. The operating margin was 15.5%.

What is the annual revenue of Sunil Healthcare?

Sunil Healthcare's sales for the year to Mar 2026 were ₹87.48 Cr; over the last twelve months they were ₹83.87 Cr.

What is the net profit of Sunil Healthcare?

Net profit for the year to Mar 2026 was ₹4 Cr, and ₹3.53 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.53.

How much debt does Sunil Healthcare have?

Sunil Healthcare reported borrowings of ₹55.86 Cr at Mar 2026, against cash and equivalents of ₹2.32 Cr.

What is the free cash flow of Sunil Healthcare?

Cash from operations was ₹22.14 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹18.62 Cr.

Loading…